Astria Therapeutics, Inc. Research and Development Expense
Astria Therapeutics, Inc. reported Research and Development Expense of $3.79 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2021-11-10
- Astria Therapeutics, Inc. research and development expense for the quarter ending 2021-09-30 was $3.79M, a 51.47% decline year-over-year.
- Astria Therapeutics, Inc. research and development expense for the quarter ending 2021-06-30 was $3.48M, a 48.47% decline year-over-year.
- Astria Therapeutics, Inc. research and development expense for the quarter ending 2021-03-31 was $2.59M, a 50.97% decline year-over-year.
- Astria Therapeutics, Inc. research and development expense for the quarter ending 2020-12-31 was $5.75M, a 34.76% increase year-over-year.
- Astria Therapeutics, Inc. research and development expense for fiscal 2020 was $25.59M, a 39.71% increase from fiscal 2019.
- Astria Therapeutics, Inc. research and development expense for fiscal 2019 was $18.32M, a 7.48% increase from fiscal 2018.
- Astria Therapeutics, Inc. research and development expense for fiscal 2018 was $17.04M, a 8.78% decline from fiscal 2017.
- Astria Therapeutics, Inc. research and development expense for fiscal 2017 was $18.68M, a 26.59% decline from fiscal 2016.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2021-09-30 | $3.79M 10-Q · filed 2021-11-10 | $7.27M derived: sum of 2 quarters · filed 2021-11-10 | $9.86M 10-Q · filed 2021-11-10 | $15.60M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $3.48M 10-Q · filed 2021-08-09 | $6.07M 10-Q · filed 2021-08-09 | $11.82M derived: sum of 3 quarters · filed 2021-08-09 | $19.62M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | $2.59M 10-Q · filed 2021-05-13 | $8.34M derived: sum of 2 quarters · filed 2021-05-13 | $16.14M derived: sum of 3 quarters · filed 2021-11-10 | $22.89M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | $5.75M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-19 | $13.55M derived: sum of 2 quarters · filed 2021-11-10 | $20.30M derived: sum of 3 quarters · filed 2021-11-10 | $25.59M 10-K/A · filed 2021-04-19 |
| 2020-09-30 | $7.81M 10-Q · filed 2021-11-10 | $14.56M derived: sum of 2 quarters · filed 2021-11-10 | $19.84M 10-Q · filed 2021-11-10 | $24.11M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $6.75M 10-Q · filed 2021-08-09 | $12.04M 10-Q · filed 2021-08-09 | $16.30M derived: sum of 3 quarters · filed 2021-08-09 | $21.00M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $5.29M 10-Q · filed 2021-05-13 | $9.55M derived: sum of 2 quarters · filed 2021-05-13 | $14.25M derived: sum of 3 quarters · filed 2021-05-13 | $19.41M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $4.26M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-19 | $8.96M derived: sum of 2 quarters · filed 2021-04-19 | $14.12M derived: sum of 3 quarters · filed 2021-04-19 | $18.32M 10-K/A · filed 2021-04-19 |
| 2019-09-30 | $4.70M 10-Q · filed 2020-11-12 | $9.86M derived: sum of 2 quarters · filed 2020-11-12 | $14.05M 10-Q · filed 2020-11-12 | $17.71M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $5.16M 10-Q · filed 2020-08-10 | $9.36M 10-Q · filed 2020-08-10 | $13.02M derived: sum of 3 quarters · filed 2020-08-10 | $16.91M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $4.20M 10-Q · filed 2020-05-12 | $7.86M derived: sum of 2 quarters · filed 2020-05-12 | $11.75M derived: sum of 3 quarters · filed 2020-05-12 | $15.99M derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $7.56M derived: sum of 2 quarters · filed 2020-03-10 | $11.79M derived: sum of 3 quarters · filed 2020-03-10 | $17.04M 10-K · filed 2020-03-10 |
| 2018-09-30 | $3.90M 10-Q · filed 2019-11-07 | $8.14M derived: sum of 2 quarters · filed 2019-11-07 | $13.38M 10-Q · filed 2019-11-07 | $17.37M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $4.24M 10-Q · filed 2019-08-08 | $9.49M 10-Q · filed 2019-08-08 | $13.47M derived: sum of 3 quarters · filed 2019-08-08 | $18.25M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $5.25M 10-Q · filed 2019-05-14 | $9.24M derived: sum of 2 quarters · filed 2019-05-14 | $14.01M derived: sum of 3 quarters · filed 2019-05-14 | $18.53M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $8.77M derived: sum of 2 quarters · filed 2019-03-14 | $13.28M derived: sum of 3 quarters · filed 2019-03-14 | $18.68M 10-K · filed 2019-03-14 |
| 2017-09-30 | $4.78M 10-Q · filed 2018-11-13 | $9.29M derived: sum of 2 quarters · filed 2018-11-13 | $14.69M 10-Q · filed 2018-11-13 | $20.95M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $4.52M 10-Q · filed 2018-08-09 | $9.92M 10-Q · filed 2018-08-09 | $16.18M derived: sum of 3 quarters · filed 2018-08-09 | $22.11M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $5.40M 10-Q · filed 2018-05-10 | $11.66M derived: sum of 2 quarters · filed 2018-05-10 | $17.59M derived: sum of 3 quarters · filed 2018-05-10 | $24.41M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $6.26M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $12.20M derived: sum of 2 quarters · filed 2018-03-15 | $19.01M derived: sum of 3 quarters · filed 2018-03-15 | $25.45M 10-K · filed 2018-03-15 |
| 2016-09-30 | $5.94M 10-Q · filed 2017-11-09 | $12.75M derived: sum of 2 quarters · filed 2017-11-09 | $19.19M 10-Q · filed 2017-11-09 | $25.86M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $6.82M 10-Q · filed 2017-08-10 | $13.25M 10-Q · filed 2017-08-10 | $19.92M derived: sum of 3 quarters · filed 2018-03-15 | $25.74M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $6.44M 10-Q · filed 2017-05-11 | $13.11M derived: sum of 2 quarters · filed 2018-03-15 | $18.92M derived: sum of 3 quarters · filed 2018-03-15 | $24.85M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $12.48M derived: sum of 2 quarters · filed 2018-03-15 | $18.41M derived: sum of 3 quarters · filed 2018-03-15 | $23.03M 10-K · filed 2018-03-15 |
| 2015-09-30 | $5.81M 10-Q · filed 2016-11-10 | $11.74M derived: sum of 2 quarters · filed 2016-11-10 | $16.36M 10-Q · filed 2016-11-10 | $20.68M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $5.93M 10-Q · filed 2016-08-11 | $10.55M 10-Q · filed 2016-08-11 | $14.87M derived: sum of 3 quarters · filed 2017-03-16 | $19.41M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $4.62M 10-Q · filed 2016-05-12 | $8.94M derived: sum of 2 quarters · filed 2017-03-16 | $13.48M derived: sum of 3 quarters · filed 2017-03-16 | $17.21M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $8.87M derived: sum of 2 quarters · filed 2017-03-16 | $12.59M derived: sum of 3 quarters · filed 2017-03-16 | $15.69M 10-K · filed 2017-03-16 |
| 2014-09-30 | $4.54M 10-Q · filed 2015-11-12 | $8.27M derived: sum of 2 quarters · filed 2015-11-12 | $11.36M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $3.72M 10-Q · filed 2015-08-13 | $6.82M 10-Q · filed 2015-08-13 | ||
| 2013-12-31 | $13.99M 10-K · filed 2016-03-15 |